The Needle-Free Future

Vaxxas' HD-MAP technology uses a patch with thousands of vaccine-coated microprojections that is applied to the skin for a few seconds to efficiently deliver vaccine to the abundant immune cells immediately below the skin surface.

Empowered To Do More

Vaxxas' approach shifts the value paradigm of vaccines. Vaxxas' HD-MAP platform has been:

  • Productized for commercial use
  • Validated in human clinical studies
  • Designed for manufacture at scale

Vaxxas In The News

Explore what's possible for you
with Careers at Vaxxas

The People And Partners Behind Vaxxas

Our Team

We have assembled a passionate and experienced team committed to rethinking what’s possible with vaccines.

Partners

We partner with world renowned organizations to maximize the impact of our technology for people globally.